Blogs
FDA stokes controversy with Alzheimer’s drug approval – what will it mean?
By Max Rex, Consultant Email: [email protected] On Monday 7th June, the FDA approved aducanumab, the first new treatment for Alzheimer’s in 18 years. Aducanumab, manufactured
June 18, 2021
